+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanoemulsions - Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140632
The global market for Nanoemulsions is estimated at US$10.9 Billion in 2023 and is projected to reach US$18.4 Billion by 2030, growing at a CAGR of 7.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Topical Administration segment, which is expected to reach US$3.9 Billion by 2030 with a CAGR of a 7.4%. The Oral Administration segment is also set to grow at 7.9% CAGR over the next 7 years.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $3.3 Billion in 2023, and China, forecasted to grow at an impressive 7.3% CAGR to reach $3.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nanoemulsions Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nanoemulsions Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nanoemulsions Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Ascendia Pharmaceuticals, Covaris, LLC, Creative Biolabs, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 43 Featured):

  • Ascendia Pharmaceuticals
  • Covaris, LLC
  • Creative Biolabs
  • Genizer LLC
  • IDEX Material Processing Technologies
  • Industrial Sonomechanics
  • LATITUDE Pharmaceuticals Inc.
  • Owen Biosciences, Inc
  • Qsonica L.L.C
  • Taiwan Liposome Company, Ltd.

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nanoemulsions - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 4: World 7-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World 7-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World 7-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 10: World 7-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World 7-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World 7-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 16: World 7-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Immunosuppressant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World 7-Year Perspective for Immunosuppressant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Antiretroviral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World 7-Year Perspective for Antiretroviral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 22: World 7-Year Perspective for Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Vasodilators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World 7-Year Perspective for Vasodilators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 25: World Nanoemulsions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 29: USA 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 31: Canada 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
JAPAN
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 35: Japan 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 37: Japan 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
CHINA
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: China 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 40: China Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 41: China 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
EUROPE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 42: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 43: Europe 7-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 46: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 47: Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
FRANCE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 48: France Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 49: France 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 50: France Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: France 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
GERMANY
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 52: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 53: Germany 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 54: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 55: Germany 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
ITALY
  • Table 56: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Italy 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 58: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 59: Italy 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
UNITED KINGDOM
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 60: UK Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 61: UK 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 62: UK Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: UK 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
REST OF EUROPE
  • Table 64: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 65: Rest of Europe 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 66: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 67: Rest of Europe 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
ASIA-PACIFIC
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Asia-Pacific 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 70: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 71: Asia-Pacific 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
REST OF WORLD
  • Table 72: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 73: Rest of World 7-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2024 & 2030
  • Table 74: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: Rest of World 7-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ascendia Pharmaceuticals
  • Covaris, LLC
  • Creative Biolabs
  • Genizer LLC
  • IDEX Material Processing Technologies
  • Industrial Sonomechanics
  • LATITUDE Pharmaceuticals Inc.
  • Owen Biosciences, Inc
  • Qsonica L.L.C
  • Taiwan Liposome Company, Ltd.

Table Information